Stay updated on Pembrolizumab for Leukoplakia Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Leukoplakia Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Leukoplakia Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Revision: v3.4.3 replaces v3.4.2. This appears to be a metadata/versioning update with no visible changes to study details or page content.
    Difference
    0.1%
    Check dated 2026-03-11T16:22:33.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    Revision: v3.4.2 added and a general funding-status notice was removed; these site-wide changes do not affect study content or participation. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T05:43:35.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Added a global site notice about a lapse in government funding and the NIH Clinical Center's operating status, and updated the page revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T04:25:09.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Added a glossary toggle and introduced the labels 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'. The revision now shows v3.4.0 and the older labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed.
    Difference
    0.2%
    Check dated 2026-01-28T02:38:06.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.3.4, replacing the previous Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:43:10.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    Added a Locations section with California as a study site and updated the revision footer to v3.3.3; the prior California Locations label and v3.3.2 footer were removed.
    Difference
    0.2%
    Check dated 2025-12-23T21:24:10.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Leukoplakia Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Leukoplakia Clinical Trial page.